About Penta
Who we are
Diversity and Inclusion
Penta ID Network
Penta Foundation Italy
Penta Foundation UK
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Call for services
Diversity & Inclusion
Brighter Future Award
Archivio
Pharmacokinetic and virological evaluations after stopping NNRTIs in children: a substudy of the PENTA 11 (TICCH) trial
Considerations in the design of randomized controlled trials evaluating the optimal time to initiate antiretroviral therapy in previously untreated HIV-1 infected patients.
Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children
Adherence and acceptability of once daily lamivudine and abacavir in HIV-1 infected children
A randomised controlled trial of genotypic HIV drug resistance testing in HIV-1 infected children: the PERA (PENTA 8)